Gujarat Kidney — 360° view

Gujarat Kidney, a company in the Hospital industry, reported revenue of ₹38 crore and net profit of ₹6.60 crore for the September 2026 quarter.

Gujarat Kidney (NSE: GKSL) closed at ₹149.28 on 20 Nov 2026. Its market capitalisation is ₹1,177 crore and it trades at 62.0 times earnings.

Share price
₹149.28 (20 Nov 2026)
Market cap
₹1,177 Cr (20 Nov 2026)
P/E
61.95 (20 Nov 2026)
Revenue
₹38 Cr (September 2026 quarter)
Net profit
₹7 Cr (September 2026 quarter)
ROCE
14.5% (FY26)
ROE
11.1% (FY26)
Book value
₹33.4 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹209.80 / ₹98.36 (20 Nov 2026)
Sector
Healthcare
Industry
Hospital
Symbol
NSE: GKSL

Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.